Alex Smith
Professor of Cancer Epidemiology, Co-Director Epidemiology & Cancer Statistics Group (ECSG)

Profile

Biography

Specialising in haematological malignancies, Alex is an epidemiologist with a strong track record in cancer research. Training and working at the universities of Cambridge and Leeds before moving to York in 2004, Alex is the Co-Director of the Epidemiology and Cancer Statistics Group. She is also a founding member of the Haematological Malignancy Research Network (HMRN); a unique, population-based, patient cohort that was established by researchers at the University of York and NHS clinicians to inform contemporary clinical practice and research in an area where good quality “real-world” data were lacking.  In addition to her leading role in HMRN, Alex is a key member of the European Myelodysplastic Syndromes Registry (EUMDS) and the Horizon 2020-funded MDS-RIGHT; under her direction, all data collected from 17 countries are managed and analysed at the University of York. 

Qualifications

• BSc
• MPhil
• PhD

University roles

• Research Data Management Committee

Research

Overview

Alex's research interests include:

• Cancer epidemiology
• Haematological malignancies
• Analysis of observational/real-world data

Projects

• Haematological Malignancy Research Network (HMRN)
• European Myelodysplastic Syndromes Registry (EUMDS)
• MDS-RIGHT (Horizon-2020)
• Facilitating informed decision-making in haemato-oncology (Improving Patient Information)
• Tumour genetics, therapeutic response and outcome
• CellBank
• Children with Down Syndrome Study (CDSS)
• ECSG Lymphoma Case Control Study (ELCCS)
• Comparing the HMRN case cohort to the general population

Research group(s)

Epidemiology & Cancer Statistics Group (ECSG)

Supervision

Alex would be interested in supervising PhDs in the following areas: cancer epidemiology and in particular haematological malignancies.

Publications

Full publications list

• Alex Smith's publications

Teaching

Postgraduate

Alex is able to supervise Masters projects in the following areas: cancer epidemiology and in particular haematological malignancies.

External activities

Memberships

• CellBank Steering Committee
• European Myelodysplastic Syndrome (EUMDS) Registry Steering Committee
• Haematology Site Specific Clinical Reference Group (National Cancer Intelligence Network)
• Haematological Malignancy Research Network Patient Involvement Committee
• Yorkshire and Humberside Haematology Network Audit committee
• MDS-RIGHT Executive Committee
• Chair, MDS-RIGHT Website Taskforce